AstraZeneca sign at British Swedish multinational pharmaceutical and biopharmaceutical company campus, San Francisco (foto Depositphotos.com)

The Netherlands stops using AstraZeneca vaccine pending side effects research

290,000 vaccinations

Earlier on Sunday, AstraZeneca issued a statement saying there is no evidence that people who have been vaccinated have a higher risk of blood clots.

No evidence

‘A careful review of all available safety data of more than 17 million people vaccinated in the European Union and United Kingdom with Corona Virus 19 vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, Deep Vein Thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,’ the company said.

‘So far across the European Union and United Kingdom, there have been 15 events of DVT (Diep Veneuze Trombose) and 22 events of pulmonary embolism reported among those given the vaccine, as of 8 March,’ the statement said. ‘This is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed Corona Virus 19 vaccines.’

The European Medicines Agency in Amsterdam has also said there is no link after fears were first published last week.